FDA Says it is Working to Investigate, Address Potential Impacts of Omicron Variant
Janet Woodcock, MD, acting commissioner of the Food and Drug Administration (FDA), says that as it has with previous emerging COVID-19 variants, the agency is “actively working with our federal…